These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18047264)

  • 41. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
    Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
    Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities.
    Bolognesi ML; Bartolini M; Mancini F; Chiriano G; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C
    ChemMedChem; 2010 Aug; 5(8):1215-20. PubMed ID: 20486153
    [No Abstract]   [Full Text] [Related]  

  • 43. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A; Gedawy EM; Kassab AE; Salam RM
    Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.
    Chao X; He X; Yang Y; Zhou X; Jin M; Liu S; Cheng Z; Liu P; Wang Y; Yu J; Tan Y; Huang Y; Qin J; Rapposelli S; Pi R
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6498-502. PubMed ID: 22981331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
    Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
    Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.
    Meng FC; Mao F; Shan WJ; Qin F; Huang L; Li XS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4462-6. PubMed ID: 22633691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
    Huang L; Miao H; Sun Y; Meng F; Li X
    Eur J Med Chem; 2014 Nov; 87():429-39. PubMed ID: 25282266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents.
    Knez D; Brus B; Coquelle N; Sosič I; Šink R; Brazzolotto X; Mravljak J; Colletier JP; Gobec S
    Bioorg Med Chem; 2015 Aug; 23(15):4442-4452. PubMed ID: 26116179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
    Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
    Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
    Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
    Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
    Bolognesi ML; Banzi R; Bartolini M; Cavalli A; Tarozzi A; Andrisano V; Minarini A; Rosini M; Tumiatti V; Bergamini C; Fato R; Lenaz G; Hrelia P; Cattaneo A; Recanatini M; Melchiorre C
    J Med Chem; 2007 Oct; 50(20):4882-97. PubMed ID: 17850125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
    Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
    J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta.
    Hebda M; Bajda M; Więckowska A; Szałaj N; Pasieka A; Panek D; Godyń J; Wichur T; Knez D; Gobec S; Malawska B
    Molecules; 2016 Mar; 21(4):410. PubMed ID: 27023510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer's disease.
    Wang Y; Yang Y; Hong KH; Ning Y; Yu P; Ren J; Ji M; Cai J
    Bioorg Chem; 2019 Jun; 87():720-727. PubMed ID: 30954836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.